Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
15
×
national blog main
new york
15
×
new york blog main
new york top stories
boston blog main
clinical trials
national top stories
boston top stories
biotech
san francisco blog main
fda
san francisco top stories
amgen
inclisiran
regeneron pharmaceuticals
sanofi
alnylam pharmaceuticals
cholesterol
deals
drugs
pcsk9 inhibitors
san diego blog main
san diego top stories
alirocumab
cancer
evolocumab
ipo
johnson & johnson
ldl
medical devices
multiple myeloma
novartis
pcsk9
praluent
raleigh-durham blog main
raleigh-durham top stories
repatha
rna interference
startups
What
drug
medicines
new
cholesterol
fda
medco
approved
deal
disease
ipo
lowering
medical
medicine
ago
alnylam
announced
big
billion
cash
community
company
company’s
data
helped
ipos
johnson
looms
meant
morning
open
past
patients
pfizer
sets
twice
week
year
abuzz
aces
acorda
Language
unset
Current search:
" new york "
×
" life sciences "
×
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum